Key Takeaways STERIS' Q2 adjusted EPS rose 15.4% to $2.47, surpassing estimates and driving a 2% stock gain. STE's Q2 revenues grew 9.8% year over year to $1.46 billion, with all business segments showing growth.STERIS lifted its fiscal 2026 EPS view to $10.15-$10.30 and raised its organic growth outlook. STERIS plc (STE) reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.47, up 15.4% from the year-ago quarter’s figure. The figure surpassed the Zacks Consensus Estimate by 3.8%.The a ...